Home LiteratureArticle Details
PMID: 8168944 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.

Infection and immunity ·Vol. 62 ·No. 5 ·1994-05-00 ·Pages 1813-9

Kelly T, Dillard JP, Yother J

Abstract

To assess the role of capsular serotypes in the virulence of Streptococcus pneumoniae, we have constructed isogenic derivatives differing only in the type of capsule expressed. Strains of types 2, 5, and 6B were converted to type 3 by transformation and selection for an erythromycin resistance marker linked to the type 3 capsule locus. Characterization studies revealed that these type 3 derivatives were indistinguishable from the type 2, type 5, and type 6B parental strains in terms of restriction enzyme fragment pattern and expression of pneumococcal surface protein A (PspA). Expression of the type 3 capsule did not alter the mouse virulence of the similarly virulent type 2 strain. However, alteration of capsule type had a profound effect on the virulence of the type 5 and type 6B derivatives. The highly virulent type 5 strain was essentially avirulent when expressing the type 3 capsule. Conversely, the 50% lethal dose of the relatively avirulent type 6B strain was reduced > 100-fold when the type 3 capsule was expressed. Thus, the serotype of capsule expressed has a major effect on virulence, and this effect is dependent upon the genetic background of the recipient strain.

MeSH Terms
Animals Bacterial Capsules/physiology Bacterial Proteins/analysis Carbohydrate Sequence Female Mice Mice, Inbred BALB C Molecular Sequence Data Restriction Mapping Streptococcus pneumoniae/chemistry,genetics,pathogenicity Virulence
Chemicals
Bacterial Proteins pneumococcal surface protein A
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Kelly T
Department of Microbiology, University of Alabama at Birmingham, 35294.
Dillard J P
Yother J
References (31)
31 references, click to expand
  1. Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene.
    J Bacteriol. 1992 Jan;174(2):610-8 PMID: 1729250
  2. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae.
    Infect Immun. 1992 Jan;60(1):111-6 PMID: 1729176
  3. Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae.
    Microb Pathog. 1992 Oct;13(4):261-9 PMID: 1363703
  4. Some biological properties of Pneumococcus type 37 and the chemistry of its capsular polysaccharide.
    J Exp Med. 1970 Sep 1;132(3):475-87 PMID: 4399979
  5. Pneumococcal type-associated variability in alternate complement pathway activation.
    Infect Immun. 1975 Oct;12(4):772-8 PMID: 329
  6. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974.
    J Clin Microbiol. 1977 Feb;5(2):154-66 PMID: 14971
  7. Classical and alternative complement pathway activation by pneumococci.
    Infect Immun. 1977 Aug;17(2):296-302 PMID: 19357
  8. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.
    Infect Immun. 1977 Nov;18(2):291-7 PMID: 21849
  9. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.
    J Immunol. 1980 May;124(5):2502-6 PMID: 7365262
  10. Growth characteristics of group A streptococci in a new chemically defined medium.
    Infect Immun. 1980 Feb;27(2):444-8 PMID: 6991416
  11. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
    Infect Immun. 1981 Jan;31(1):228-35 PMID: 7216447
  12. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.
    J Exp Med. 1981 Mar 1;153(3):694-705 PMID: 7252411
  13. Mouse Igg3 antibodies are highly protective against infection with Streptococcus pneumoniae.
    Nature. 1981 Nov 5;294(5836):88-90 PMID: 6170000
  14. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    J Clin Invest. 1982 Jan;69(1):85-98 PMID: 7054244
  15. Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody.
    Infect Immun. 1982 Apr;36(1):184-8 PMID: 7076292
  16. Granulocyte phagocytosis and killing virulent and avirulent serotypes of Streptococcus pneumoniae.
    J Lab Clin Med. 1982 Aug;100(2):279-87 PMID: 6284848
  17. Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types.
    Infect Immun. 1983 Feb;39(2):993-9 PMID: 6832828
  18. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae.
    J Exp Med. 1984 Aug 1;160(2):386-97 PMID: 6381634
  19. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 5.
    Carbohydr Res. 1985 Jul 1;140(1):101-10 PMID: 4053092
  20. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production.
    J Infect Dis. 1986 Apr;153(4):682-93 PMID: 3950449
  21. Clinical and epidemiologic studies of pneumococcal infection in children.
    Pediatr Infect Dis. 1986 Mar-Apr;5(2):201-7 PMID: 3952010
  22. Genetic control of the susceptibility to pneumococcal infection.
    Curr Top Microbiol Immunol. 1986;124:103-20 PMID: 3086036
  23. Transformation of encapsulated Streptococcus pneumoniae.
    J Bacteriol. 1986 Dec;168(3):1463-5 PMID: 3782044
  24. Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 2, a reinvestigation.
    Carbohydr Res. 1988 Oct 15;182(1):111-7 PMID: 3242800
  25. The structure of the Streptococcus pneumoniae type 29 polysaccharide: a re-examination.
    Carbohydr Res. 1988 Dec 31;184:288-91 PMID: 3242814
  26. Analysis of a surface protein of Streptococcus pneumoniae recognised by protective monoclonal antibodies.
    Microb Pathog. 1986 Dec;1(6):519-31 PMID: 3508498
  27. Genetic analysis of Streptococcus pneumoniae serotypes with the use of DNA fingerprinting.
    J Infect Dis. 1989 Jul;160(1):76-82 PMID: 2732518
  28. Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae.
    Microb Pathog. 1990 Jan;8(1):61-9 PMID: 2333033
  29. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.
    Infect Immun. 1990 Oct;58(10):3293-9 PMID: 1698178
  30. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type.
    Infect Immun. 1991 Jan;59(1):222-8 PMID: 1987036
  31. Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae.
    Infect Immun. 1992 May;60(5):1957-62 PMID: 1563788
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1994-05-00
Pages
1813-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC186414
Subset
IM
Grants
NIAID NIH HHS · AI28457 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]